The CHEK2 gene I157T mutation and other alterations in its proximity increase the risk of sporadic colorectal cancer in the Czech population.

[1]  P. Souček,et al.  Analysis of CHEK2 FHA domain in Czech patients with sporadic breast cancer revealed distinct rare genetic alterations , 2008, Breast Cancer Research and Treatment.

[2]  O. Peralta,et al.  Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population , 2008, Breast Cancer Research and Treatment.

[3]  A. Jakubowska,et al.  Constitutional CHEK2 mutations are associated with a decreased risk of lung and laryngeal cancers. , 2008, Carcinogenesis.

[4]  S. Ahn,et al.  The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation , 2008, Breast Cancer Research and Treatment.

[5]  R. Peto,et al.  Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. , 2007, Human molecular genetics.

[6]  C. Banwell,et al.  The role of ATM in breast cancer development , 2007, Breast Cancer Research and Treatment.

[7]  B. Haffty,et al.  P7 The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation , 2007 .

[8]  J. Kładny,et al.  Epistatic Relationship between the Cancer Susceptibility Genes CHEK2 and p27 , 2007, Cancer Epidemiology Biomarkers & Prevention.

[9]  J. Kładny,et al.  Germline CHEK2 mutations and colorectal cancer risk: different effects of a missense and truncating mutations? , 2007, European Journal of Human Genetics.

[10]  S. Seal,et al.  A Multicenter Study of Cancer Incidence in CHEK2 1100delC Mutation Carriers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[11]  H. Nevanlinna,et al.  The CHEK2 gene and inherited breast cancer susceptibility , 2006, Oncogene.

[12]  Sibylle Mittnacht,et al.  Trans‐activation of the DNA‐damage signalling protein kinase Chk2 by T‐loop exchange , 2006, The EMBO journal.

[13]  P. Devilee,et al.  CHEK2 1100delC mutation is frequent among Russian breast cancer patients , 2006, Breast Cancer Research and Treatment.

[14]  T. Walsh,et al.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. , 2006, JAMA.

[15]  L. Aaltonen,et al.  CHEK2 I157T associates with familial and sporadic colorectal cancer , 2005, Journal of Medical Genetics.

[16]  D. Ilencikova,et al.  The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic , 2005, Breast Cancer Research and Treatment.

[17]  J. Lubiński,et al.  CHEK2 is a multiorgan cancer susceptibility gene. , 2004, American journal of human genetics.

[18]  E. Ostrander,et al.  Frequency of CHEK2 mutations in a population based, case–control study of breast cancer in young women , 2004, Breast Cancer Research.

[19]  Päivi Heikkilä,et al.  CHEK2 variant I157T may be associated with increased breast cancer risk , 2004, International journal of cancer.

[20]  Nazneen Rahman,et al.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.

[21]  P. Edwards,et al.  Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1 , 2004, Cytogenetic and Genome Research.

[22]  J. Schleutker,et al.  CHEK2 variants associate with hereditary prostate cancer , 2003, British Journal of Cancer.

[23]  L. Aaltonen,et al.  CHEK2 1100delC and colorectal cancer , 2003, Journal of medical genetics.

[24]  David I. Smith,et al.  Mutations in CHEK2 associated with prostate cancer risk. , 2003, American journal of human genetics.

[25]  C. Canman,et al.  Phosphorylation of Threonine 68 Promotes Oligomerization and Autophosphorylation of the Chk2 Protein Kinase via the Forkhead-associated Domain* , 2002, The Journal of Biological Chemistry.

[26]  Michael B Yaffe,et al.  Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2. , 2002, Molecular cell.

[27]  Jing Chen,et al.  Characterization of Tumor-associated Chk2 Mutations* , 2001, The Journal of Biological Chemistry.

[28]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[29]  E. Kwak,et al.  Hereditary colorectal cancer syndromes: an overview. , 2007, Clinical colorectal cancer.

[30]  J. Benítez,et al.  The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population , 2004, International journal of cancer.